Macular telangiectasia: Patterns of distribution of macular pigment and response to supplementation

Retina

Volumn 30, Issue 8, 2010, Pages 1282-1293

  Zeimer, Meike B ^a   Krömer, Isabel ^a   Spital, Georg ^a   Lommatzsch, Albrecht ^a   Pauleikhoff, Daniel ^a  

^a ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

lutein; retinal diseases; retinal pigments; retinal vessels; telangiectasis; visual acuity; xanthophylls

Indexed keywords

ANTIOXIDANT; CAROTENOID; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOFLUORESCENCE IMAGING; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; HUMAN; MACULAR TELANGIECTASIA; MALE; OPTICAL DENSITY; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PIGMENT EPITHELIUM; RETINA FOVEA; SUPPLEMENTATION; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADULT; AGED; DIETARY SUPPLEMENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LUTEIN; MACULA LUTEA; MALE; MIDDLE AGED; RETINAL DISEASES; RETINAL PIGMENTS; RETINAL VESSELS; TELANGIECTASIS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS; XANTHOPHYLLS;

EID: 77957603446     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181e096dd     Document Type: Article

References (31)

1. Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 1982;100:769-780.
2. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993;100:1536-1546.
3. Yannuzzi LA, Bardal AM, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124:450-460.
4. Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. V. Retinal telangiectasis. Arch Ophthalmol 1968;80:592-605.
5. Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. VI. X-ray irradiation, carotid artery occlusion, collagen vascular disease, and vitritis. Arch Ophthalmol 1968;80:606-617.
6. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 2007;84:718-728.
7. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 1992;32:105-110.
8. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 1988;29:843-849.
9. Sommerburg OG, Siems WG, Hurst JS, et al. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 1999;19:491-495.
10. Bernstein PS, Khachik F, Carvalho LS, et al. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 2001;72:215-223.
11. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006;124:1038-1045.
12. Delori FC, Goger DG, Hammond BR, et al. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 2001;18:1212-1230.
13. Helb HM, Charbel Issa P, Van Der Veen RL, et al. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 2008;28:808-816.
14. Charbel Issa P, Berendschot TT, Staurenghi G, et al. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2008;49:1172-1177.
15. Zeimer MB, Padge B, Heimes B, Pauleikhoff D. Macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina 2010;30:586-595.
16. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:S786-S806.
17. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:S766-S785.
18. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:S741-S756.
19. Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 2002;240:666-671.
20. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol 2006;244:1565-1574.
21. Rougier MB, Delyfer MN, Korobelnik JF. [Measuring macular pigment in vivo]. J Fr Ophtalmol 2008;31:445-453.
22. Jahn C, Wustemeyer H, Brinkmann C, et al. Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 2005;243:222-227.
23. Liew SH, Gilbert CE, Spector TD, et al. Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci 2005;46: 4430-4436.
24. Wüstemeyer H, Moessner A, Jahn C, Wolf S. Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 2003;241:647-651.
25. Stockman AS, Sharpe LT, Merbs S. Spectral sensitivities of human cone visual pigments determined in vivo and in vitro. Methods Enzymol 2000;316:626-650.
26. Dachtler M, Glaser T, Kohler K, Albert K. Combined HPLC-MS and HPLC-NMR on-line coupling for the separation and determination of lutein and zeaxanthin stereoisomers in spinach and in retina. Anal Chem 2001;73:667-674.
27. Helb HM, Charbel Issa P, Pauleikhoff D, Scholl HPN, Holz FG. Macular pigment density and distribution in patients with macular telangiectasia. 2006. Available at: www.iovs.org.
28. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997;64:211-218.
29. Albini TA, Benz MS, Coffee RE, et al. Optical coherence tomography of idiopathic juxtafoveolar telangiectasia. Ophthalmic Surg Lasers Imaging 2006;37:120-128.
30. Cakir M, Kapran Z, Basar D, et al. Optical coherence tomography evaluation of macular edema after intravitreal triamcinolone acetonide in patients with parafoveal telangiectasis. Eur J Ophthalmol 2006;16:711-717.
31. Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 2007;245: 783-788.